Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Vandana Singh

Walgreens Launches Clinical Trial Business

  • Walgreens Boots Alliance Inc (NASDAQ:WBA) has launched its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research. 
  • Walgreens will combine the flexible clinical trial model with its vast data on patient insights, partner-enabled health and technology capabilities, and in-person and virtual care options.
  • The introduction of Walgreens' clinical trial offerings coincides with recent steps taken by the FDA to increase racial and ethnic diversity in clinical trials.
  • The company notes that 20% of drugs have a variation in responses across ethnic groups, yet 75% of trial participants are white. In comparison, only 11% are Hispanic, and fewer than 10% are Black and Asian.
  • "Best known for its chain of drugstores, Walgreens has been looking to expand beyond its core business and spent $5.5 billion last year to take majority stakes in two health care providers, VillageMD and CareCentrix," Reuters reported.
  • "With the clinical trials business, the company plans to use its vast trove of data and new services to help cut costs for drugmakers and capture a share of the roughly $83 billion market," the report noted.
  • Price Action: WBA shares are down 1.25% at $40.21 during the market session on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.